{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T17:04:43Z","timestamp":1788023083570,"version":"build-2784847793"},"reference-count":46,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2024.1804","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T09:56:13Z","timestamp":1718272573000},"source":"Crossref","is-referenced-by-count":7,"title":["Proton pump inhibitor use is associated with increased liver steatosis"],"prefix":"10.3892","volume":"21","author":[{"given":"Hongsheng","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Third Affiliated Hospital of Sun Yat\u2011Sen University, Guangzhou, Guangdong 510630, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingkai","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Third Affiliated Hospital of Sun Yat\u2011Sen University, Guangzhou, Guangdong 510630, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Third Affiliated Hospital of Sun Yat\u2011Sen University, Guangzhou, Guangdong 510630, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Shenzhen People's Hospital, Second Clinical Medical College of Jinan University, First Affiliated Hospital of South University of Science and Technology, Shenzhen, Guangdong 518020, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Third Affiliated Hospital of Sun Yat\u2011Sen University, Guangzhou, Guangdong 510630, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixi","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Third Affiliated Hospital of Sun Yat\u2011Sen University, Guangzhou, Guangdong 510630, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdukyamu","family":"Smayi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Third Affiliated Hospital of Sun Yat\u2011Sen University, Guangzhou, Guangdong 510630, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Third Affiliated Hospital of Sun Yat\u2011Sen University, Guangzhou, Guangdong 510630, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Third Affiliated Hospital of Sun Yat\u2011Sen University, Guangzhou, Guangdong 510630, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"key20240725111854_b1-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999-2012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"key":"key20240725111854_b2-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2021.12.247","article-title":"AGA clinical practice update on de-prescribing of proton pump inhibitors: Expert review","volume":"162","author":"Targownik","year":"2022","journal-title":"Gastroenterology"},{"key":"key20240725111854_b3-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00228-010-0871-9","article-title":"Appropriateness of treatment recommendations for PPI in hospital discharge letters","volume":"66","author":"Ahrens","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"key20240725111854_b4-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1053\/j.ajkd.2019.07.012","article-title":"Proton pump inhibitors and the Kidney: Implications of current evidence for clinical practice and when and how to deprescribe","volume":"75","author":"Al-Aly","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"key20240725111854_b5-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"e1771","DOI":"10.1212\/WNL.0000000000207747","article-title":"Cumulative use of proton pump inhibitors and risk of dementia: The atherosclerosis risk in communities study","volume":"101","author":"Northuis","year":"2023","journal-title":"Neurology"},{"key":"key20240725111854_b6-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"key":"key20240725111854_b7-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s12012-021-09637-2","article-title":"Proton pump inhibitor exposure and acute myocardial infarction risk: A nested cohort study","volume":"21","author":"Tseng","year":"2021","journal-title":"Cardiovasc Toxicol"},{"key":"key20240725111854_b8-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cgh.2012.12.011","article-title":"Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: A meta-analysis","volume":"11","author":"Lo","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20240725111854_b9-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/17474124.2023.2204229","article-title":"Vitamin B12 deficiency and use of proton pump inhibitors: A systematic review and meta-analysis","volume":"17","author":"Choudhury","year":"2023","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"key20240725111854_b10-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3748\/wjg.v25.i17.2058","article-title":"Proton pump inhibitor: The dual role in gastric cancer","volume":"25","author":"Joo","year":"2019","journal-title":"World J Gastroenterol"},{"key":"key20240725111854_b11-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/apt.14391","article-title":"Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: Results from ERCHIVES","volume":"47","author":"Li","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"key20240725111854_b12-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1053\/j.gastro.2022.03.052","article-title":"The association between proton pump inhibitor exposure and key liver-related outcomes in patients with cirrhosis: A veterans affairs cohort study","volume":"163","author":"Mahmud","year":"2022","journal-title":"Gastroenterology"},{"key":"key20240725111854_b13-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.3748\/wjg.v25.i33.4933","article-title":"Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis","volume":"25","author":"De Roza","year":"2019","journal-title":"World J Gastroenterol"},{"key":"key20240725111854_b14-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/jgh.13737","article-title":"Proton pump inhibitors: Risks of long-term use","volume":"32","author":"Eusebi","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"key20240725111854_b15-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of proton pump inhibitors: Expert review and best practice advice from the American gastroenterological association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"key":"key20240725111854_b16-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1097\/HEP.0000000000000023","article-title":"CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population","volume":"77","author":"Vilar-Gomez","year":"2023","journal-title":"Hepatology"},{"key":"key20240725111854_b17-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"key20240725111854_b18-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"e1438","DOI":"10.1016\/j.cgh.2021.06.029","article-title":"Physical activity is associated with nonalcoholic fatty liver disease and significant fibrosis measured by FibroScan","volume":"20","author":"Kim","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20240725111854_b19-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of fibroscan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"issue":"154752","key":"key20240725111854_b20-BR-21-2-01804","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154752","article-title":"Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes","volume":"121","author":"Ciardullo","year":"2021","journal-title":"Metabolism"},{"key":"key20240725111854_b21-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"key20240725111854_b22-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.cgh.2021.05.052","article-title":"Sugar-sweetened beverages are associated with increased liver stiffness and steatosis among apparently healthy adults in the United States","volume":"20","author":"Leung","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20240725111854_b23-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/hep.32207","article-title":"High-quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population","volume":"75","author":"Vilar-Gomez","year":"2022","journal-title":"Hepatology"},{"key":"key20240725111854_b24-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/liv.14652","article-title":"The association of sex steroid hormone concentrations with non-alcoholic fatty liver disease and liver enzymes in US men","volume":"41","author":"Phan","year":"2021","journal-title":"Liver Int"},{"key":"key20240725111854_b25-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12072-022-10429-1","article-title":"Association of age at first birth and risk of non-alcoholic fatty liver disease in women: Evidence from the NHANES","volume":"17","author":"Yang","year":"2023","journal-title":"Hepatol Int"},{"key":"key20240725111854_b26-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","article-title":"Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease","volume":"17","author":"Siddiqui","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20240725111854_b27-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"101133","key":"key20240725111854_b28-BR-21-2-01804","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2023.101133","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2024","journal-title":"Ann Hepatol"},{"key":"key20240725111854_b29-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"key20240725111854_b30-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"key20240725111854_b31-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.livres.2022.11.001","article-title":"Hepatic transcriptome profiling reveals early signatures associated with disease transition from non-alcoholic steatosis to steatohepatitis","volume":"6","author":"Magee","year":"2022","journal-title":"Liver Res"},{"key":"key20240725111854_b32-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/MCG.0000000000000503","article-title":"Histamine H2-receptor antagonist use is associated with lower prevalence of nonalcoholic fatty liver disease: A population-based study from the national health and nutrition examination survey, 2001-2006","volume":"50","author":"Shen","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"key20240725111854_b33-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/jgh.15236","article-title":"Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study","volume":"36","author":"Pyo","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"issue":"837","key":"key20240725111854_b34-BR-21-2-01804","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00796-x","article-title":"Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus","volume":"8","author":"Llorente","year":"2017","journal-title":"Nat Commun"},{"key":"key20240725111854_b35-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/MCG.0000000000001847","article-title":"Long-term use of proton pump inhibitors is associated with an increased risk of nonalcoholic fatty liver disease","volume":"58","author":"Huang","year":"2024","journal-title":"J Clin Gastroenterol"},{"key":"key20240725111854_b36-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/MED.0000000000000031","article-title":"Proton pump inhibitor therapy and potential long-term harm","volume":"21","author":"Corleto","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"820","key":"key20240725111854_b37-BR-21-2-01804","doi-asserted-by":"publisher","DOI":"10.3390\/nu12030820","article-title":"Gut microbiota dysbiosis in patients with biopsy-proven nonalcoholic fatty liver disease: A cross-sectional study in Taiwan","volume":"12","author":"Tsai","year":"2020","journal-title":"Nutrients"},{"key":"key20240725111854_b38-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jhep.2021.11.029","article-title":"The fecal mycobiome in non-alcoholic fatty liver disease","volume":"76","author":"Demir","year":"2022","journal-title":"J Hepatol"},{"key":"key20240725111854_b39-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1053\/j.gastro.2019.06.028","article-title":"Microbiome signatures associated with steatohepatitis and moderate to severe fibrosis in children with nonalcoholic fatty liver disease","volume":"157","author":"Schwimmer","year":"2019","journal-title":"Gastroenterology"},{"issue":"4982","key":"key20240725111854_b40-BR-21-2-01804","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18754-5","article-title":"Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD","volume":"11","author":"Lee","year":"2020","journal-title":"Nat Commun"},{"key":"key20240725111854_b41-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/jgh.12667","article-title":"Use of proton pump inhibitors decrease cellular oxidative burst in patients with decompensated cirrhosis","volume":"30","author":"Garcia-Martinez","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"key20240725111854_b42-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"e2671","DOI":"10.1210\/clinem\/dgac231","article-title":"Prolonged use of proton pump inhibitors and risk of type 2 diabetes: Results from a large population-based nested case-control study","volume":"107","author":"Ciardullo","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"key20240725111854_b43-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1111\/bcp.15182","article-title":"Proton pump inhibitors are associated with incident type 2 diabetes mellitus in a prospective population-based cohort study","volume":"88","author":"Czarniak","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"key20240725111854_b44-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"8592","DOI":"10.3390\/nu7105416","article-title":"Association of proton pump inhibitor (PPI) use with energy intake, physical activity, and weight gain","volume":"7","author":"Czwornog","year":"2015","journal-title":"Nutrients"},{"key":"key20240725111854_b45-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/MCG.0000000000000542","article-title":"Study of gender differences in proton pump inhibitor dose requirements for GERD: A double-blind randomized trial","volume":"51","author":"Helgad\u00f3ttir","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"key20240725111854_b46-BR-21-2-01804","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1038\/ajg.2014.351","article-title":"Risk factors for Barrett's esophagus compared between African Americans and non-Hispanic Whites","volume":"109","author":"Nguyen","year":"2014","journal-title":"Am J Gastroenterol"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T08:19:35Z","timestamp":1721895575000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2024.1804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,6,13]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2024.1804","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]},"article-number":"116"}}